Literature DB >> 7622205

Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague.

S E Leary1, E D Williamson, K F Griffin, P Russell, S M Eley, R W Titball.   

Abstract

The gene encoding V antigen from Yersinia pestis was cloned into the plasmid expression vector pGEX-5X-2. When electroporated into Escherichia coli JM109, the recombinant expressed V antigen as a stable fusion protein with glutathione S-transferase. The glutathione S-transferase-V fusion protein was isolated from recombinant E. coli and cleaved with factor Xa to yield purified V antigen as a stable product. Recombinant V antigen was inoculated intraperitoneally into mice and shown to induce a protective immune response against a subcutaneous challenge with 3.74 x 10(6) CFU of virulent Y. pestis. Protection correlated with the induction of a high titer of serum antibodies and a T-cell response specific for recombinant V antigen. These results indicate that V antigen should be a major component of an improved vaccine for plague.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7622205      PMCID: PMC173387          DOI: 10.1128/iai.63.8.2854-2858.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

Review 1.  The mucosal immune system: from fundamental concepts to vaccine development.

Authors:  J R McGhee; J Mestecky; M T Dertzbaugh; J H Eldridge; M Hirasawa; H Kiyono
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

2.  Preparation of monoclonal antibody to V antigen from Yersinia pestis.

Authors:  K Sato; R Nakajima; F Hara; T Une; Y Osada
Journal:  Contrib Microbiol Immunol       Date:  1991

3.  Plague immunization. V. Indirect evidence for the efficacy of plague vaccine.

Authors:  D C Cavanaugh; B L Elisberg; C H Llewellyn; J D Marshall; J H Rust; J E Williams; K F Meyer
Journal:  J Infect Dis       Date:  1974-05       Impact factor: 5.226

4.  Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in BALB/c mice.

Authors:  W J Simpson; R E Thomas; T G Schwan
Journal:  Am J Trop Med Hyg       Date:  1990-10       Impact factor: 2.345

5.  Molecular analysis of lcrGVH, the V antigen operon of Yersinia pestis.

Authors:  S B Price; K Y Leung; S S Barve; S C Straley
Journal:  J Bacteriol       Date:  1989-10       Impact factor: 3.490

6.  Roles of V antigen in promoting virulence and immunity in yersiniae.

Authors:  T Une; R R Brubaker
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

7.  The Yersinia pestis V antigen is a regulatory protein necessary for Ca2(+)-dependent growth and maximal expression of low-Ca2+ response virulence genes.

Authors:  S B Price; C Cowan; R D Perry; S C Straley
Journal:  J Bacteriol       Date:  1991-04       Impact factor: 3.490

8.  Differential clearance and host-pathogen interactions of YopE- and YopK- YopL- Yersinia pestis in BALB/c mice.

Authors:  S C Straley; M L Cibull
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

9.  Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha.

Authors:  R Nakajima; R R Brubaker
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

10.  Proteolysis of V antigen from Yersinia pestis.

Authors:  R R Brubaker; A K Sample; D Z Yu; R J Zahorchak; P C Hu; J M Fowler
Journal:  Microb Pathog       Date:  1987-01       Impact factor: 3.738

View more
  65 in total

1.  Probing molecular interactions in intact antibody: antigen complexes, an electrospray time-of-flight mass spectrometry approach.

Authors:  M A Tito; J Miller; N Walker; K F Griffin; E D Williamson; D Despeyroux-Hill; R W Titball; C V Robinson
Journal:  Biophys J       Date:  2001-12       Impact factor: 4.033

2.  Deletion of amino acids 29 to 81 in adhesion protein YadA of Yersinia enterocolitica serotype O:8 results in selective abrogation of adherence to neutrophils.

Authors:  A Roggenkamp; K Ruckdeschel; L Leitritz; R Schmitt; J Heesemann
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis.

Authors:  Jim Hill; Catherine Copse; Sophie Leary; Anthony J Stagg; E Diane Williamson; Richard W Titball
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

4.  Protein binding between PcrG-PcrV and PcrH-PopB/PopD encoded by the pcrGVH-popBD operon of the Pseudomonas aeruginosa type III secretion system.

Authors:  Leonard R Allmond; Timur J Karaca; Vinh N Nguyen; Thong Nguyen; Jeanine P Wiener-Kronish; Teiji Sawa
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

5.  Protein microarray for profiling antibody responses to Yersinia pestis live vaccine.

Authors:  Bei Li; Lingxiao Jiang; Qifeng Song; Junxin Yang; Zeliang Chen; Zhaobiao Guo; Dongsheng Zhou; Zongmin Du; Yajun Song; Jin Wang; Hongxia Wang; Shouyi Yu; Jian Wang; Ruifu Yang
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

6.  Administration of antibody to the lung protects mice against pneumonic plague.

Authors:  Jim Hill; Jim E Eyles; Stephen J Elvin; Gareth D Healey; Roman A Lukaszewski; Richard W Titball
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

7.  Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV.

Authors:  Kristin L DeBord; Deborah M Anderson; Melanie M Marketon; Katie A Overheim; R William DePaolo; Nancy A Ciletti; Bana Jabri; Olaf Schneewind
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

8.  The ADP-ribosylating toxin, AexT, from Aeromonas salmonicida subsp. salmonicida is translocated via a type III secretion pathway.

Authors:  Sarah E Burr; Katja Stuber; Joachim Frey
Journal:  J Bacteriol       Date:  2003-11       Impact factor: 3.490

9.  Amino acid residues 196-225 of LcrV represent a plague protective epitope.

Authors:  Lauriane E Quenee; Bryan J Berube; Joshua Segal; Derek Elli; Nancy A Ciletti; Deborah Anderson; Olaf Schneewind
Journal:  Vaccine       Date:  2009-12-10       Impact factor: 3.641

10.  An IL-12 DNA vaccine co-expressing Yersinia pestis antigens protects against pneumonic plague.

Authors:  Hitoki Yamanaka; Teri Hoyt; Richard Bowen; Xinghong Yang; Kathryn Crist; Sarah Golden; Massimo Maddaloni; David W Pascual
Journal:  Vaccine       Date:  2008-10-26       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.